English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
11 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Strikes deal with DOGE
Wins longest-ever Iditarod
Pleads not guilty
Plane engine catches fire
Man hit by motorcade, dies
Permanently shuts route
‘Ted Lasso’ is coming back
Kupp signs with Seahawks
Visits DOJ for speech
SpaceX launches Crew-10
Court lifts Trump's DEI block
Coffee creamer recall
Influential WY senator dies
Senate confirmation hearing
Top intelligence agency visit
ISIS leader killed in Iraq
Consumer sentiment drops
Legendary sportswriter dies
Hamas to release hostage
Gold rises to new heights
To cut 2,000+ jobs
March megastorm
Laceration hazard recall
反馈